secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001493152-23-019073
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics announces 2023 annual meeting voting results; directors elected, auditor ratified
--------------------------------------------------------------------------------

- 4,469,519 shares (~53% of outstanding) represented at May 25, 2023 meeting.
- William B. Hayes (2,452,279 for) and Anthony Maddaluna (2,544,652 for) elected as Class II directors.
- Ratification of Haskell & White LLP as auditor for FY2023: 4,446,392 for, 22,167 against, 960 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315223019073/0001493152-23-019073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315223019073/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer